Seven-Day Mealtime Insulin Patch Rolls Out Nationally

CeQur says its Simplicity wearable mealtime insulin patch is now available nationally with two changes: wear for up to seven days and a new 1-unit dosing option alongside the existing 2-unit version.

The company announced the wider availability Tuesday. The FDA clearances for the longer wear period and additional dosing option were announced in June, so this is an availability announcement, not a new approval issued today.

The patch delivers rapid-acting insulin under the skin through a small, flexible cannula. The wearer presses its dosing mechanism to deliver insulin in 1-unit or 2-unit increments, depending on the version prescribed. It is intended for mealtime and correction doses, not automatic dosing or a replacement for every part of a person's insulin treatment.

The device is intended for adults with diabetes. Patients should discuss suitability, insulin dosing and their wider treatment plan with their healthcare professional.

National availability is reported by the manufacturer. The announcement does not establish the price, insurance coverage or availability at every pharmacy. More information about the device is available on CeQur's patient website.